37 min listen
Planning patient-focused value chains in cell and gene therapy
Planning patient-focused value chains in cell and gene therapy
ratings:
Length:
24 minutes
Released:
Jul 22, 2022
Format:
Podcast episode
Description
Cell-based gene therapyBiomedical research and treatmentAutologous- when patient’s own cells are modified outside the body and reintroduced to the patientAllogenic- cells isolated from a healthy donor. Cell therapy aims to treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body. With cell therapy, cells are cultivated or modified outside the body before being injected into the patient. The cells may originate from the patient (autologous cells) or a donor (allogeneic cells).Gene therapy aims to treat diseases by replacing, inactivating or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).Some therapies are considered both cell and gene therapies. These therapies work by altering genes in specific types of cells and inserting them into the body.
Released:
Jul 22, 2022
Format:
Podcast episode
Titles in the series (34)
Building your team for successful digital transformation and beyond: Our guest on this episode of the Big Ideas in Supply Chain podcast is Ronan Stephens, the chief supply chain officer at Ipsen. The biopharmaceutical company recently experienced double digital growth, which created opportunities to develop a new wave of supply chain talent. Ronan talks about building the DNA of the supply chain organization - a process that needed people with the skills to deliver on three core areas for the business: Maintain healthy inventory, deliver new medicines as quickly as possible and be cash efficient. Ronan also talks about his vision for the future, connecting the end-to-end supply chain with a team focused on anticipating market needs rather than reacting to it. Listen now! by Big Ideas in Supply Chain